The shareholders of AUXESIS PHARMA HOLDING AB (publ) with organization number 559195-6486 are hereby invited to the annual general meeting on June 16, 2023 at 15.00 at Ramberg Law at Jakobsbergsgatan 13 in Stockholm Sweden.
We are excited to invite you to our first Investor Forum monday the 30th of january at the Karolinska Institute, Huddinge, Sweden.
On site you will have the opportunity to meet the founder and CEO Roar Adelsten, the research supervisor Professor Moustapha Hassan and key people in the company’s management team.
AUXESIS PHARMA HOLDING AB (publ) Investor Forum will cover the history of our product development, how it has changed over time and where it is headed in the future. We will also discuss the latest research in this field. Welcome!
AUXESIS PHARMA HOLDING AB (publ) register of shareholders is in process of being digitalised and transferred to the Euroclear system. As a client to Euroclear Sweden, Auxesis Pharma becomes a part of the hub in the Swedish financial market. With advantages such as reduced administration and easier to raise capital, the company also becomes prepared for a listing on the stock exchange in the near future. A register of shareholders is a list that shows who owns shares in the company. According to the Swedish Companies Act (ABL), all limited companies must have a register of shareholders.
AUXESIS PHARMA HOLDING AB (publ) is now registered with the Swedish Companies Registration Office as a Public Limited Company (PLC) with a share capital of SEK 500,000. A PLC has the right to distribute shares, subscription rights and other securities to the public.